课题基金 / 基金详情

Intracellular metabolism and mechanism of action of antileukemic agents studied by means of automatic simulation system of drug concentration.

Intracellular metabolism and mechanism of action of antileukemic agents studied by means of automatic simulation system of drug concentration.
利用药物浓度自动模拟系统研究抗白血病药物的细胞内代谢及作用机制。
批准号:
06671083
负责人:
UEDA Takanori
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996

项目摘要

项目成果

UEDA Takanori的其他基金

相似基金

相关文献

中文摘要
翻译
在准确反映临床药代动力学的条件下研究抗白血病药物的代谢和作用是非常重要的。本研究采用台盼蓝拒染法(TB)和克隆形成法(CA),在去年建立的自动模拟系统调节药物浓度的条件下,研究了阿糖胞苷(ara-C)对白血病细胞株(K562)的生长抑制作用。在临床常规剂量阿糖胞苷(100 mg/m_2)和曲线下面积(AUC)相等的条件下,与对照组相比,TB组在2、4、8、16小时的细胞生长率分别为73%、53%、39%、45%,CA组分别为76%、72%、34%、15%。用CA法观察到阿糖胞苷对细胞生长的抑制作用更明显,并将柔红霉素(DNR)的抑制作用用模拟法与常规培养法进行了比较。在模拟DNR 40 mg/m_230min灌注条件下,细胞生长为对照组的82%(Cmax ; 0.20 μ M,t1/2 β; 4.35hr)。另一方面,在常规培养系统的条件下,通过24小时孵育获得相同的生长抑制效果需要0.022 μ M。自动模拟培养系统所需的培养液浓度是常规培养系统的9倍左右。这一结果与去年阿糖胞苷的情况不同,去年阿糖胞苷的差异约为80倍,这表明差异可能取决于每种药物的作用和代谢。此外,自动模拟系统在评价药物的抗肿瘤作用方面上级传统的培养系统。CA法比TB法更适合作为判断细胞生长抑制效果的方法。目前,我们正在利用自动模拟系统研究同时模拟阿糖胞苷和柔红霉素的条件下细胞生长抑制。
英文摘要
It is very important to study the metabolism and action of antileukemic agents under the condition which precisely reflect the clinical pharmacokinetics. In this year, we studied cell growth inhibition of leukemic cell line (K562) by cytosine arabinoside (ara-C), using method of trypan blue dye exclusion assay (TB) and clonogenic assay (CA) under the drug concentration regulated by automatic simulation system which was established last year. Under the condition of clinically regular dose ara-C (100mg/m_2) and equal area under the curve (AUC) each other, the cell growth by 2,4,8,16 hour infusion was 73%, 53%, 39%, 45% using TB,and 76%, 72%, 34%, 15% using CA respectively, compared with control. More obvious time dependent inhibition by ara-C was observed using CA.We also compared the effect of daunorubicin (DNR) by simulation method with the data by conventional culture system. The cell growth was 82% of the control using CA under simulated condition with DNR 40mg/m_2 30min.infusion (Cmax ; 0.20 muM,t1/2beta ; 4.35 hr). On the other side, 0.022 muM was required to get the same growth inhibition effect by 24 hours incubation under condition of conventional culture system. About 9 times higher concentration was required in automatic simulation system compared with conventional culture system. This result was different from the the case with the ara-C in last year where the difference was about 80 times, suggesting the difference might depend on the action and metabolism of each drug. In addition, it was suggested that to estimate the anti-tumor effect of drug, automatic simulation system is superior than conventional culture system. And it was also suggested that CA was better method than TB to judge the cell growth inhibition effect. Now we are studying cell growth inhibition under condition to simulate ara-C and DNR simultaneously using automatic simulation system.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
Tohyama, K.: "Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro : comparison with normal blast cells." Exp. Hematol.22. 539-545 (1994)
Tohyama, K.:“骨髓增生异常综合征纯化母细胞对体外集落刺激因子反应的改变:与正常母细胞的比较。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
上田孝典: "抗白血病薬-新薬と合理的投与法の試み-" 臨床血液. 37. 635-639 (1996)
Takanori Ueda:“抗白血病药物-新药试验和合理给药方法”《临床血液》37。635-639(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fukushima,T.: "Superior cytotoxic potency of mitoxantrone in interaction with DNA : Comparison with that of daunorubicin" Oncol.Res.8・2. 95-100 (1996)
Fukushima, T.:“米托蒽醌与 DNA 相互作用的卓越细胞毒性效力:与柔红霉素的比较”Oncol.Res.8・2 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueda,T.: "Recent developments with novel anthracyclines for the treatment of haematological malignancies" Exp.Opin.Invest.Drugs. 5. 1639-1646 (1996)
Ueda,T.:“新型蒽环类药物治疗血液恶性肿瘤的最新进展”Exp.Opin.Invest.Drugs。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    A comparative study on legalization of lifelong learning policy in China
    • 批准号:
      26381121
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2014
    • 负责人:
      UEDA Takanori
    • 依托单位:
    Eliminating CPU Bottleneck of File I/O on Ultra High Speed Storage Environments
    • 批准号:
      23650053
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2011
    • 负责人:
      UEDA Takanori
    • 依托单位:
    A File Cache Mechanism Considering Access Cost and Being Suitable for Many-core CPU Environment
    • 批准号:
      21800061
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.7万
    • 财政年份:
      2009
    • 负责人:
      UEDA Takanori
    • 依托单位:
    Tailor-made therapy based on pharmacogenomic strategy for refractory leukemia due to multifactorial drug resistance
    • 批准号:
      19591102
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      UEDA Takanori
    • 依托单位:
    海外基金